Madhya Pradesh has officially banned the sale of Coldrif cough syrup across the state. This urgent action follows the tragic deaths of 11 children in Chhindwara district, with investigations confirming the syrup contained toxic levels of diethylene glycol (DEG). Consequently, state authorities are seizing all available stock and have suspended the sale of other medicines manufactured by Sresan Pharmaceuticals.
Chief Minister Mohan Yadav announced an ex-gratia payment of Rs 4 lakh to the families of the deceased children. Furthermore, the state government will cover the complete medical expenses for children still undergoing treatment. The CM stressed that strict action awaits anyone found responsible for this grave incident.
Understanding the Coldrif Cough Syrup Contamination
Samples of the Coldrif syrup were sent for testing immediately after the initial reports of child deaths surfaced. Lab reports on Saturday morning conclusively identified the samples as substandard. The analysis from the Government Drug Analyst at the Drug Testing Laboratory in Chennai revealed a alarming 48.6% diethylene glycol content in the syrup. Diethylene glycol is a highly toxic substance, posing extreme health hazards, and is commonly used in industrial solvents, not pharmaceuticals.
Upon confirmation of this dangerous contamination, a comprehensive ban on the sale of Coldrif cough syrup was imposed throughout Madhya Pradesh. A joint investigation team has been established at the state level to meticulously probe the matter. This team will work to ascertain all aspects of the contamination and distribution.
Regulatory Actions and Public Safety Measures
The Controller of Food and Drug Administration Madhya Pradesh, Dinesh Kumar Maurya, has instructed all senior drug inspectors and drug inspectors across the state to immediately stop the sale and distribution of Coldrif cough syrup. Officials must seal any existing stocks according to the Drugs and Cosmetics Act, 1940, and its rules; destruction is not permitted. Therefore, samples are being collected from these sealed stocks and sent to government laboratories for further testing.
The ban extends beyond Coldrif cough syrup; the sale and use of all other medicines produced by Sresan Pharmaceuticals have also been suspended with immediate effect. This proactive measure aims to ensure public safety. Authorities are collecting samples of these other drugs for legal testing, and they have ordered strict monitoring of their movement within the state. Consequently, the Central Drugs Standard Control Organisation (CDSCO) has initiated risk-based inspections across 19 drug manufacturing units in six states.
These decisive government actions highlight the serious commitment to protecting public health and ensuring drug quality. Moreover, a doctor who prescribed the syrup has been arrested, and a case has been filed against the manufacturer, Sresan Pharmaceuticals, from Kanchipuram, Tamil Nadu. To understand the implications of such events on drug safety and regulatory practices, consider exploring courses in safe prescribing and public health management.
Frequently Asked Questions
Q1: What is diethylene glycol?
Diethylene glycol (DEG) is a toxic chemical often used in industrial solvents, antifreeze, and brake fluids. Ingesting even small amounts can cause acute kidney failure and be fatal.
Q2: What actions has the Madhya Pradesh government taken regarding the Coldrif cough syrup?
The Madhya Pradesh government has banned the sale and distribution of Coldrif cough syrup statewide, announced ex-gratia payments to affected families, pledged to cover treatment expenses, and launched an investigation. They have also suspended the sale of all other products from Sresan Pharmaceuticals.
Q3: Which company manufactured the contaminated Coldrif cough syrup?
The contaminated Coldrif cough syrup was manufactured by Sresan Pharmaceuticals, located in Kanchipuram, Tamil Nadu.
References
- MP CM announces ex-gratia of Rs 4 lakh to families of children who died inChhindwara – ETHealthworld
- India probes possible cough syrup link to deaths of at least nine children – Al Jazeera
- Madhya Pradesh Bans Coldrif Cough Syrup Following Children’s Deaths from Kidney Failure – Newsonair
- Madhya Pradesh doctor arrested after 14 children die of cough syrup prescribed by him | Top 7 updates – The Indian Express
- 11 children deaths in MP: Doctor who prescribed ‘poisoned’ cough syrup arrested; Tamil Nadu-based firm booked | Bhopal News – The Times of India
- Indian states ban cough syrup linked to child deaths – CNA
- Coldrif row: Why are states banning the cough syrup | Explained – Hindustan Times
- Doctor arrested after 16 children die in Madhya Pradesh from toxic cough syrup – India Today
- Chennai company’s Coldrif syrup banned after child deaths reported – The News Minute
- Madhya Pradesh bans cough syrup linked to deaths of 9 children – The Hindu
- MP bans Coldrif cough syrup sale following death of 14 children; toxic chemical found in samples – The Economic Times
- Centre makes U-turn on cough syrup; Madhya Pradesh, Rajasthan, TN ban it – The New Indian Express
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.